Peregrine Pharmaceuticals Inc. (PPHM) to Manufacture Human Coagulation Factor Clinical Candidate for Catalyst Biosciences
Avid Bioservices is a wholly owned subsidiary of Peregrine Pharmaceuticals Inc. Avid Bioservices has signed a manufacturing supply agreement with Catalyst Biosciences, Inc. to produce clinical-grade material in support of their clinical candidate, CB 813, an improved version of factor VIIa for the treatment of acute bleeding in hemophilia patients. Hemophilia is a hereditary disorder that affects approximately one in 5,000 males born in the United States. When a person with hemophilia is injured, he does not bleed harder or faster than a person without hemophilia, he bleeds longer. Small cuts or surface bruises are usually not a problem, but…